Conversation with The Cancer Letter Georgetown’s Weiner and Hackensack’s Pecora tell us how they created a consortium spanning 233 miles May 10, 2019Vol.45 No.19By Paul Goldberg
Conversation with The Cancer Letter Hirsch: Syapse collaboration with Amgen will focus on real world evidence and hematologic malignancies May 03, 2019Vol.45 No.18By Matthew Bin Han Ong
Conversation with The Cancer Letter NIH’s Lauer: “We have contacted over 55 institutions” April 26, 2019Vol.45 No.17By Paul Goldberg
Conversation with The Cancer Letter Pisters: “Trust is broken when a grant reviewer decides that an idea should be better done elsewhere” April 26, 2019Vol.45 No.17By Paul Goldberg
Conversation with The Cancer Letter Fred Hirsch: New center focuses Mount Sinai’s thoracic oncology programs April 12, 2019Vol.45 No.15By Paul Goldberg
Conversation with The Cancer LetterFree Penn’s Brooks: Surgeons should study oncologic endpoints for years, not just 30-day outcomes April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
Conversation with The Cancer LetterFree MD Anderson’s Hunt and Selber: We will study immediate and long-term outcomes of robotic mastectomy in a prospective trial April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
Conversation with The Cancer LetterFree MSK’s Kirstein: Robotic mastectomy not demonstrated to be safe for treatment or prevention of breast cancer April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
Conversation with The Cancer Letter Lee Schwartzberg tells us how three practices banded together to adapt to today’s cancer care and data revolution March 29, 2019Vol.45 No.13By Matthew Bin Han Ong
Conversation with The Cancer Letter James Willson: CPRIT is money well spent March 22, 2019Vol.45 No.12By Claire Dietz and Matthew Bin Han Ong
